📊 Score Breakdown
Offering Ability
100
Cash Runway
0
Float Risk
42
Warrant Exposure
90
Convertible Debt—
🌦️ Dilution Forecast
⛈️
Warning
High probability of dilution event
52%
📜 Warrant Exercise
60%
• Massive warrant overhang: 290% of shares outstanding
• Warrant risk score very high (90/100)
📉 Score Deterioration
50%
• Score rose 40 points recently (worsening)
• Score in HIGH risk zone (62/100)
💰 Capital Raise
38%
• Active shelf registration ($75M, 1537% of market cap)
• Active ATM program with $31M remaining capacity
💹 Market Data
Market Cap$4.88M
Shares Outstanding3.49M
Float2.12M
Cash$10.27M
Debt$719.0K
Short InterestN/A
🏛 Institutional Holdings
8 institutional holders · 32.8K shares
#1
UBS Group AG
11.2K shares
#2
Two Sigma Investments, LP
6.9K shares
#3
Virtu Financial LLC
5.6K shares
+ 5 more holders Sign up free to view →
📉 Short Interest
Short Interest37.9K
Days to Cover1.0
% of Float1.8%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL CONVERTIBLE
Mar 31, 2026
xbrl
XBRL WARRANT
Mar 31, 2026
S-3
SHELF
May 04, 2026
424B3
ATM
Apr 16, 2026
EFFECT
EFFECT
Apr 15, 2026
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for ARTL
📊 ARTL FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 ARTL Signal Convergence & Dark Pool Activity — StonkWhisper
📄 ARTL Dilution Risk Analysis — Full In-Depth Report
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.